BAUSCH HEALTH Stock Price (NYSE:BHC)

Add to My Stocks
$22.59 $0.08 (0.35%) BHC stock closing price Jul 20, 2018 (Closing)
Prev Close* : $22.67
Market Cap:
$7.91B
Day Low: $22.47
52 Week Low: $10.94
Open: $22.71
Volume: -
Day High: $22.79
52 Week High: $27.79
Dividend:
0.00

BAUSCH HEALTH Stock Articles & Video

more news on BHC stock

BAUSCH HEALTH News - From Partners

Company News For Jun 19, 2018   by Zacks on Jun 19, 2018

BHC Stockcharts

View BHC PE ratio, PS ratio stocks charts and compare with peers.
BHC Chart
Note: Compare BAUSCH HEALTH stock price history with the index and industry peers.

BAUSCH HEALTH Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
0.94
PB ratio (
price to book ratio
)
1.69

BAUSCH HEALTH Returns

ROE
(return on equity)
-19%

BAUSCH HEALTH Financial Ratios

Asset Turnover
0.22
Receivables Turnover
4.1
Debt to Equity
5.59
Dividend Yield
0%

BHC Industry Peers

Company Price Change (%)
Neurocrine Biosciences (NBIX)103.430.38 (0.37%)
Nektar Therapeutics (NKTR)48.730.35 (0.71%)
Pfizer (PFE)37.330.03 (0.08%)
Astrazeneca (AZN)37.170.14 (0.38%)
Johnson & Johnson (JNJ)125.850.09 (0.07%)
Cooper Companies (COO)248.580.59 (0.24%)
Astellas Pharma (ALPMY)16.150.09 (0.56%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
PTC Therapeutics (PTCT)39.983.43 (9.38%)
Adamis Pharma (ADMP)3.80.15 (4.11%)
Rigel Pharma (RIGL)3.10.12 (4.03%)
La Jolla Pharma (LJPC)32.271.21 (3.9%)
CASI Pharma (CASI)7.350.27 (3.81%)
CTI BioPharma (CTIC)2.350.08 (3.52%)
ArQule (ARQL)5.380.17 (3.26%)
Top gainers from Medical-Drugs industry
* As of Jul 20, 2018
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)2.810.11 (3.77%)
Redhill Biopharma (RDHL)9.960.39 (3.77%)
Achaogen (AKAO)7.140.27 (3.64%)
Infinity Pharma (INFI)1.910.07 (3.54%)
Lannett Co (LCI)12.350.45 (3.52%)
Galectin Therapeutics (GALT)5.620.2 (3.44%)
Tesaro Inc (TSRO)39.240.99 (2.46%)
Top losers from Medical-Drugs industry
* As of Jul 20, 2018

BAUSCH HEALTH Financial Statements

income statement20172016201520142013
Net Sales or Revenues8.72B9.67B10.45B8.26B5.77B
Net Income2.4B-2.41B-291.7M913.5M-866.14M
Total Operating Expense6.07B7.63B6.33B3.97B4.27B
View BAUSCH HEALTH income statement
balance sheet20172016201520142013
Total Assets37.5B43.53B48.96B26.35B27.97B
Total Liabilities31.55B40.27B42.93B20.92B22.74B
Shareholders Equity5.94B3.26B6.03B5.43B5.23B
View BAUSCH HEALTH balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities844M-110M-822.2M-668.4M-378.29M
Net Cash from (used by) Operating Activities2.29B2.09B2.2B2.29B1.04B
Increase (Decrease) in Prop Plant And Equipment3.08B-36M-222.4M1.2B-74.22M
View BAUSCH HEALTH cash flow statement

BAUSCH HEALTH Stock Message Board